Advertisement
Advertisement
BLTE
Belite Bio, Inc - ADR
158.87
USDSponsored
-2.19
-1.36%
Aug 24, 15:58 UTC -4
Closed
After-Market
158.15
-0.72
-0.45%
BLTE Earnings Reports
Positive Surprise Ratio
BLTE beat 5 of 15 last estimates.
33%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.84
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/+29.23%
Belite Bio, Inc - ADR earnings per share and revenue
On Aug 13, 2026, BLTE reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.80 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.09% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.84 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.11
Actual
$0.35
Surprise
+198.38%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Alpha Cognition Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.40
Surprise
-0.05%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
PDS Biotechnology Corporation Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.18
Surprise
-35.75%
FAQ
What were Belite Bio, Inc - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Belite Bio, Inc - ADR reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Belite Bio, Inc - ADR's Q2 2026 earnings?
The stock price moved down -2.09%, changed from $166.28 before the earnings release to $162.80 the day after.
When is Belite Bio, Inc - ADR expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Belite Bio, Inc - ADR's next earnings report?
Based on 6
analysts, Belite Bio, Inc - ADR is expected to report EPS of -$0.84 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement